Skip to content

Crossover Study of the LMA SupremeTM vs Ambu-Aura GainTM

A Randomized Crossover Study of the LMA SupremeTM Versus Ambu-Aura GainTM in Adult Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02458794
Enrollment
200
Registered
2015-06-01
Start date
2015-09-30
Completion date
2016-04-30
Last updated
2015-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Morbidity

Brief summary

The Ambu-Aura GainTM is a new extraglottic airway device which brings together features of both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use - prevention of disease transmission). In the following randomized, crossover study, the investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the Ambu-Aura GainTM and the LMA SupremeTM in paralyzed, anesthetized patients.

Interventions

ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion

DEVICEAmbu-Aura GainTM

Sponsors

Krankenhaus Bozen
CollaboratorOTHER
Schulthess Klinik
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA 1 or 2 * Age 19-65 yr * Written informed consent

Exclusion criteria

* Difficult airway * Non fasted * BMI \> 35

Design outcomes

Primary

MeasureTime frameDescription
oropharyngeal seal pressure5 minutesOropharyngeal leak pressure was determined by closing the expiratory valve of the anesthesia breathing system and a fixed gas flow of 3 l minute-1. The airway pressure at which an equilibrium was reached was noted (maximum allowed 40 cm H2O).

Secondary

MeasureTime frameDescription
anatomic position5 minutesThe anatomic position was assessed by passing a fiberoptic scope through the airway tube stopping 0,5 cm prior to the end of the tube. The airway tube view was scored using an established scoring system.

Countries

Italy, Switzerland

Contacts

Primary ContactChristian Keller, MD MSc
christian.keller@kws.ch++41443857462

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026